ARTICLE SUMMARY:
XableCath has developed a low cost, manual metal-tipped over-the-wire catheter designed to remain in the true lumen of the artery. The start-up positions it as the treatment of first resort for complex lesions like severe and chronic total occlusions in the peripheral vasculature.
Worldwide, more than 200 million people are afflicted with peripheral artery disease (PAD) and the ranks are growing as a result of increasing longevity and the rising prevalence of diabetes.
